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293TT cellsBKPyV and JCPyV are closely related, ubiquitous human pathogens that cause disease in immunocompro-
mised patients. The DNA sequence of the regulatory regions distinguishes two forms of these viruses, desig-
nated archetype and rearranged. Although cell culture systems exist for rearranged BKPyV and JCPyV,
currently there is no robust cell culture system to study the archetype viruses. Large T antigen (TAg) is a vi-
rally encoded protein required to initiate viral DNA synthesis. Because archetype virus produces undetectable
levels of TAg, we hypothesized that TAg overexpression would stimulate archetype virus replication. Efﬁcient
propagation of the archetype forms of BKPyV and JCPyV was observed in 293TT cells, human embryonic kid-
ney cells overexpressing SV40 TAg. Importantly, the archetypal structure of the regulatory region was main-
tained during viral growth. Signiﬁcant replication was not observed for Merkel cell, KI, or WU
polyomaviruses. 293TT cells provide a means of propagating archetype BKPyV and JCPyV for detailed study.
© 2011 Elsevier Inc. All rights reserved.Introduction
BK polyomavirus (BKPyV) and JC polyomavirus (JCPyV) are close-
ly related human viruses originally isolated by two independent
groups from patient samples in 1971 (Gardner et al., 1971; Padgett
et al., 1971). BKPyV, JCPyV, and the related simian virus 40 (SV40)
all share close to 70% whole genome sequence identity and differ
mainly in their regulatory or transcriptional control regions
(Imperiale, 2001). Both BKPyV and JCPyV are thought to be con-
tracted in childhood or early adulthood. For BKPyV, the adult popula-
tion seroprevalence is reached by the age of 10 and is estimated to be
between 65% and 90% (Kean et al., 2009; Knowles, 2001). For JCPyV,
the seroprevalence is lower than that of BKPyV, roughly 20% by the
age of ten, and increasing to up to about 50% by the age of 70 (Kean
et al., 2009). After what is thought to be a primary asymptomatic in-
fection, these viruses disseminate to and persist in the urinary tract.
In immunosuppressed patients, the viruses can reactivate and cause
serious disease in speciﬁc sites. BKPyV can reactivate in bone marrow
transplant patients to cause hemorrhagic cystitis in the bladder, and
in kidney transplant patients to cause polyomavirus-associated ne-
phropathy in the kidney (Ahsan and Shah, 2006). JCPyV can cause
the fatal demyelinating disease, progressive multifocal leukoencepha-
lopathy (PML), in which viral growth is restricted to glial cells of the
brain, particularly in AIDS patients (Dorries et al., 1979).Drive, 5724 Medical Science II,
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rights reserved.BKPyV and JCPyV are small, non-enveloped, icosahedral viruses
with circular double-stranded DNA genomes (Imperiale and Major,
2007). The genomes are divided into three genetic regions: the
early coding region, the late coding region, and the regulatory region,
which is also called the non-coding control region (NCCR) in BKPyV.
The regulatory region contains the origin of DNA replication and the
promoters for the divergently transcribed early and late coding re-
gions. The early coding region encodes the non-structural T antigen
proteins that are responsible for inducing a cellular environment con-
ducive to replication and initiating viral DNA synthesis. The late coding
region encodes the structural capsid proteins VP1, VP2, and VP3, and
agnoprotein.
Two forms of the viral genomes of BKPyV and JCPyV exist, which
are designated archetype and rearranged based on the DNA sequence
of the regulatory regions. The archetypal regulatory region is divided
into deﬁned blocks of sequence that are duplicated or deleted in the
rearranged variants. In BKPyV, the archetype virus NCCR is divided
into ﬁve blocks of sequence designated O, for the origin of replication,
P, Q, R, and S (Moens and Van Ghelue, 2005). The JCPyV archetype
regulatory region is similarly divided into blocks of sequence desig-
nated a, b, c, d, e, and f, with the origin of replication located between
block a and the early genes (Jensen and Major, 2001). The archetype
form of both viruses is thought to be the transmissible form that is ca-
pable of establishing a persistent infection in the host. For BKPyV, the
archetype form can be periodically isolated in the urine of healthy in-
dividuals as a result of transient reactivation events (Doerries, 2006;
Knowles, 2001). In contrast, rearranged variants are most often iso-
lated from the serum of patients with BKPyV disease (Gosert et al.,
2008). Similarly, JCPyV archetype virus isolation is often limited to
the urine or urinary tract sites such as the kidney in healthy
Fig. 1. TAg expression limits archetype BKPyV replication in RPTE cells. A. RPTE cells
were transfected with recircularized archetype (A) or rearranged (R) viral genomes.
Total cell protein was harvested 4 dpt and 25 μg of protein was analyzed by Western
blotting for the expression of TAg and GAPDH. B. RPTE cells were transfected with
recircularized archetype genome and empty vector (–) or BKPyV TAg cDNA. Total cell
protein was harvested 4 dpt and 30 μg was analyzed by Western blotting for the ex-
pression of TAg, VP1, and GAPDH. C. RPTE cells were transfected with recircularized ar-
chetype genome and empty vector (–) or BKPyV TAg cDNA, and low molecular weight
DNA was harvested 4 dpt. Samples were linearized, digested with DpnI, and analyzed
by Southern blotting. Arrow indicates the replicated viral genome. Input DNA is not visible
on this exposure. Mock, mock transfection. Lin, linearized BKPyV plasmid control.
Lin/DpnI, linearized andDpnI-digested BKPyV plasmid control. The blots shown are repre-
sentative of three independent experiments.
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ranged form of JCPyV can be isolated from the brain and lymphocytes
in addition to the kidneys and urine in people with and without PML
(Loeber and Dorries, 1988; Tornatore et al., 1992; White et al., 1992;
Yogo et al., 1990). Rearranged variants of BKPyV and JCPyV are able to
grow readily in the current cell culture models of renal proximal tu-
bule epithelial (RPTE) cells and human fetal glial cells, respectively
(Low et al., 2004; Padgett et al., 1977). To date, cell culture systems
to study the archetype form of BKPyV and JCPyV have been extremely
limited. However, it is important to be able to grow the archetype
form of these polyomaviruses to understand the natural history of in-
fection, develop means to prevent transmission and reactivation, and
to aid in the search for a naturally permissive cell type for archetype
virus in the host.
There is only one report of archetype BKPyV propagation in cell
culture, but that propagation was not efﬁcient. Archetype virus was
shown to have limited replication capacity in a human endothelial
cell line (Hanssen Rinaldo et al., 2005). Infectious progeny were not
detected until 35 days post transfection (dpt) and only 4% of cells
were infected upon secondary infection of the endothelial cells re-
gardless of the multiplicity of infection of the inoculum. Additionally,
the authors showed that while the archetype virus NCCR conﬁgura-
tion was maintained, there were a signiﬁcant number of rearranged
variants identiﬁed in the progeny. Attempts to culture archetype
JCPyV have been somewhat more successful. Archetype JCPyV has
weak DNA replication ability in POJ cells, which are transformed
human fetal glial cells that express JCPyV large T antigen (TAg)
(Daniel et al., 1996). Archetype JCPyV DNA also replicates in COS-7
cells, monkey cells that constitutively express SV40 TAg, but infec-
tious progeny are not produced (Hara et al., 1998). Additionally, it
has recently been shown that archetype JCPyV propagates in COS-7
cells stably expressing HIV-1 Tat after 32 days in culture
(Nukuzuma et al., 2009). HIV-1 Tat acts in coordination with the cel-
lular protein Purα to stimulate viral DNA replication (Daniel et al.,
2001). Importantly, these systems did not attain large scale propagation
of archetype viruses. Therefore, in this study we sought to develop an
improved culture system for archetype BKPyV and JCPyV.
We have previously shown that the BKPyV NCCR is the major ge-
netic region that determines the ability of rearranged variants and not
archetype virus to replicate viral DNA in RPTE cells (Broekema et al.,
2010). We created a system that allowed us to exchange the major
genetic regions between archetype and rearranged forms and
showed that the rearranged NCCR present in an archetype virus back-
ground is sufﬁcient for viral replication. It is also known that, in addi-
tion to the contribution of the NCCR, the early coding region product,
TAg, is required in trans for viral replication by binding to the viral origin
of replication to initiate DNA synthesis (Fanning and Zhao, 2009).
Previous research has shown that SV40 TAg is capable of binding
the origins of both JCPyV and BKPyV and initiating replication of their
viral DNAs in vitro as well as in vivo (Daniel et al., 1996; Mahon et al.,
2009; Sock et al., 1993). Additionally, BKPyV TAg and JCPyV TAg have
some capacity to function in BKPyV, JCPyV, and SV40 DNA replication.
In this study we show that archetype BKPyV produces undetectable
levels of TAg in cell culturemodels that support viral replication of rear-
ranged variants, whose TAg production is robust. This knowledge, com-
bined with data from previous studies, led us to ask if TAg
overexpression could stimulate archetype BKPyV and JCPyV replication.
We looked at the contribution of TAg transient overexpression by
cotransfecting a BKPyV TAg cDNA with the viral genome and found
that this could stimulate viral DNA replication and capsid protein pro-
duction in archetype virus, which suggests progeny viruswas produced.
Therefore, we reasoned that constitutive high TAg levels may support
archetype virus propagation. We chose to assess the contribution of
TAg overexpression to viral replication in 293TT cells, human embryonic
kidney cells constitutively expressing SV40 TAg (Buck et al., 2004), and
successfully developed ameans to efﬁciently propagate both BKPyV andJCPyV archetype virus for future study. Additionally, we determined
whether SV40 TAg overexpression could stimulate the replication of
other unculturable human polyomaviruses: Merkel cell polyomavirus
(MCPyV), KI polyomavirus (KIPyV), and WU polyomavirus (WUPyV).
293TT cells were found to only propagate viruses closely related to
SV40whereasMCPyV, KIPyV, andWUPyV all failed to replicate efﬁcient-
ly in these cells.
Results
Archetype BKPyV produces undetectable level of TAg in RPTE cells
Rearranged forms of BKPyV are able to replicate in the natural host
cell culture model RPTE cells, whereas archetype virus is unable to ef-
ﬁciently replicate in culture (Broekema et al., 2010; Hara et al., 1986;
Watanabe and Yoshiike, 1985). TAg is the viral protein responsible for
initiating viral DNA synthesis as a result of binding to the origin of
replication to recruit DNA polymerase (Fanning and Zhao, 2009).
Therefore, TAg protein production was ﬁrst assessed in cells trans-
fected with rearranged or archetype viral genomes to determine if
the TAg level was a factor limiting archetype virus replication in
RPTE cells. Recombinant archetype (Dik) and rearranged (Dunlop)
BKPyV genomeswere excised from the vector backbone, recircularized,
and transfected into RPTE cells. We assayed for TAg production by col-
lecting total cell proteins 4 dpt and immunoblotting for TAg protein
(Fig. 1A). TAg was only detectable when the rearranged genome, and
not the archetype genome, was transfected into RPTE cells. Since TAg
is necessary for viral DNA replication, we hypothesized that limited
TAg expression from the archetype NCCR production was likely one
key factor limiting the propagation of archetype virus in RPTE cells
and that TAg overexpression, therefore,may be able to rescue archetype
virus replication. Transient TAg overexpression in RPTE cells, by
cotransfecting a BKPyV TAg cDNA with the archetype genome, did re-
sult in a detectable level of capsid protein production at 4 dpt
(Fig. 1B). Viral DNA replication was assessed in the same experiment
by a DpnI resistance assay, which distinguishes methylated input plas-
midDNA fromunmethylatedDNA that has been replicated in eukaryotic
cells (Pipas et al., 1983). At 4 dpt, low molecular weight DNA was
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ting. Replication was not detectable in control cells transfected with
empty vector and the archetype genome, consistent with previous re-
sults (Broekema et al., 2010). However, viral DNA replication was de-
tectable when the archetype genome was cotransfected with BKPyV
TAg cDNA. This demonstrates that TAg overexpression can stimulate ar-
chetype virus replication and capsid protein production.
Archetype BKPyV and JCPyV replicate efﬁciently and produce capsid
protein in 293TT cells
To determine whether sustained higher levels of TAg overexpres-
sion could promote robust archetype BKPyV replication, we per-
formed viral replication assays in 293TT cells, human embryonic
kidney cells that constitutively express high levels of SV40 TAg
(Buck et al., 2004). 293TT cells contain an SV40 TAg expression plas-
mid in addition to an integrated SV40 genome which produces low
levels of TAg due to a splicing bias that favors small t antigen. We rea-
soned that SV40 is a closely related virus and it has been shown that
SV40 TAg can drive DNA replication from the origins of BKPyV and
JCPyV (Daniel et al., 1996; Lynch and Frisque, 1990; Mahon et al.,
2009). Recombinant archetype and rearranged BKPyV genomes
were excised from the vector backbone, recircularized, and trans-
fected into 293TT cells. At 4 dpt, low molecular weight DNA was iso-
lated, linearized, digested with DpnI, and assayed by Southern
blotting (Fig. 2A). Day 4 was chosen because rearranged variant rep-
lication can be easily detected at this time point (Broekema et al.,
2010). Replication was quantiﬁed by normalizing the replicated ge-
nome band to a DpnI-digested input band, which controls for trans-
fection efﬁciency. The quantiﬁed value of archetype virus DNA
replication was set to 100. In two of four independent experiments,
archetype virus replicated better than the rearranged virus while inFig. 2. Archetype BKPyV and JCPyV replicate efﬁciently in 293TT cells. A. 293TT cells
were transfected with recircularized archetype (A) or rearranged (R) BKPyV genomes,
and low molecular weight DNA was harvested at 4 dpt. Samples were linearized,
digested with DpnI, and analyzed by Southern blotting. The right panel shows a darker
exposure where the input DpnI digested bands and digested plasmid controls are visi-
ble. Arrow indicates the replicated viral genome. M, HindIII digest of pGEM-TU (size of
bands in kb). Lin, linearized BKPyV plasmid control. Lin/DpnI, linearized and DpnI-
digested BKPyV plasmid control. B. Low molecular weight DNA was harvested 2 and
3 dpt from archetype JCPyV transfection and analyzed by Southern blotting. Light and
dark exposures are shown as in A. C, D. Analysis of VP1 expression. C. Total cell protein
was harvested from 293TT cells 4 dpt and 90 μg of protein was analyzed by Western
blotting for BKPyV VP1 and GAPDH expression. Mock, mock transfection. D. Total cell
protein was harvested 4 dpt and 60 μg of protein was analyzed by Western blotting
for JCPyV VP1 and GAPDH expression. The blots shown are representative of three in-
dependent experiments.the other two experiments there were almost equal levels of replica-
tion between the two viruses. When the data was averaged for all ex-
periments, rearranged variant replication was 83.8% that of archetype
virus with a standard deviation of 29.8%. This was not statistically dif-
ferent from that of archetype virus (Student's t test p value of 0.3).
Therefore, both archetype and rearranged BKPyV replicated well in
293TT cells. This is in contrast to RPTE cells, in which rearranged
BKPyV replicates ~75 fold better than archetype virus (Broekema et
al., 2010). Archetype JCPyV replication was also assessed at 2 and
3 dpt by DpnI resistance assay (Fig. 2B). Archetype JCPyV efﬁciently
replicated in 293TT cells, and somewhat faster than BKPyV. We also
measured capsid protein production in 293TT cells for archetype
BKPyV and JCPyV by collecting total cell proteins 4 dpt and Western
blotting for VP1 protein. Consistent with the replication assay results,
archetype BKPyV and JCPyV produced capsid protein in 293TT cells
(Figs. 2C and D). Additionally, archetype BKPyV appeared to produce
more VP1 than rearranged. Encouraged by the results with these ar-
chetype viruses, we assessed replication ability and capsid protein
production of three other unculturable human polyomaviruses:
MCPyV, KIPyV, and WUPyV. These viruses were not capable of signiﬁ-
cant replication as measured by a DpnI resistance assay (data not
shown). Furthermore, we obtained capsid protein antibody for KIPyV
andWUPyV and these viruses did not produce detectable levels of cap-
sid protein as assayed by immunoblotting (data not shown). Capsid
production was not tested for MCPyV due to lack of an available anti-
body. These results show that archetype BKPyV and JCPyV but not
MCPyV, KIPyV, and WUPyV are able to replicate their DNA and express
late proteins in 293TT cells.
Infectious progeny production of archetype BKPyV and JCPyV
Production of VP1 by archetype virus suggests that viral progeny
are also produced in 293TT cells. To test whether archetype virus
was in fact producing infectious progeny virus we harvested whole
cell lysates 7 dpt. We then infected fresh 293TT cells with 1:2 dilu-
tions of the transfection lysate in serum-free medium and assessed
capsid protein production over time as a measure of infection. We
could not use BKPyV or JCPyV TAg protein expression as a readout
of infection because of the abundant SV40 TAg expression in 293TT
cells, which is detected by the SV40 TAg pAb416 antibody. Therefore,
VP1 capsid protein was assessed at 1, 4, and 7 days post infection
(dpi). Archetype BKPyV lysates showed increased capsid protein pro-
duction over time in 293TT cells. Consistent with the transfection
DNA replication and capsid protein results, archetype virus appeared
to have somewhat accelerated kinetics of infection when compared to
the rearranged variant (Fig. 3A). Infection of fresh 293TT cells with
7 dpt lysates of archetype JCPyV also resulted in an increased VP1
protein over time (Fig. 3B). These results show that archetype
BKPyV and JCPyV are able to produce infectious progeny in 293TT
cells. Lysates harvested from cells transfected with the KIPyV and
WUPyV genomes were unable to produce infectious progeny as mea-
sured by passage on fresh 293TT cells (data not shown). This result is
consistent with the inability of these viruses to replicate DNA in
293TT cells.
Previously, it has been shown that rearrangements in the NCCR of
archetype BKPyV can occur when it is passaged in cell culture
(Rubinstein et al., 1991). Therefore, the integrity of the regulatory re-
gion of the virus in the lysates used for infection was conﬁrmed by
PCR amplifying the regulatory region from one transfection lysate,
cloning the PCR products, and sequencing. Three clones from the
rearranged BKPyV lysate were sequenced and no mutations were
found. Nine clones from the archetype BKPyV lysate also had no rear-
rangements or point mutations. Ten clones were sequenced from the
JCPyV regulatory region, none of which contained any rearrange-
ments. Three of the ten, however, did contain base changes, at
G108A, G235A , and C253T, where 1 is the ﬁrst nucleotide of the
Fig. 3. Archetype BKPyV and JCPyV produce infectious progeny in 293TT cells. Cell ly-
sates were harvested from 293TT cells 7 dpt. The lysates were then used to infect
fresh 293TT cells. A. Total cell protein was harvested on 1, 4, and 7 dpi with BKPyV ly-
sate, and 50 μg of protein was analyzed byWestern blotting for BKPyV VP1 and GAPDH
expression. A, archetype. R, rearranged. B. Total cell protein was harvested on 1, 4, and
7 dpi with JCPyV lysate, and 50 μg of protein was analyzed for JCPyV VP1 and GAPDH
expression. The blots shown are representative of three independent experiments.
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and therefore all archetype BKPyV and JCPyV clones sequenced main-
tained an archetype regulatory region structure.
Puriﬁcation of archetype BKPyV from 293TT cells and virion morphology
We next examined the physical properties of the BKPyV produced
in 293TT cells. Archetype and rearranged BKPyV from 293TT cells
were puriﬁed on CsCl gradients. The refractive index of the mature
virus band for both forms was measured and the density was calculat-
ed to be 1.34 g/cm3, the expected polyomavirus density. Puriﬁed
virus morphology was then examined by transmission electron mi-
croscopy (TEM) (Fig. 4). As a comparison, infectious rearranged
BKPyV viral particles from Vero cells, which support rearranged vari-
ant replication, are shown. The average sizes of the archetype virions
were 44.9+/−2.0 nm (n=85), rearranged virions were 46.6+/
−2.5 nm (n=34), and particles puriﬁed from Vero cells were 46.4+/Fig. 4. Morphology of BKPyV produced in 293TT cells. Virus was puriﬁed from cells by
CsCl gradient centrifugation. Mature virus particles were applied to grids as described
in the text. Viral particles were visualized by negative staining at a magniﬁcation of
180,000×. Archetype virions from 293TT cells are shown in the left column, rearranged
virions from the same cells in the middle column, and rearranged virions puriﬁed from
Vero cells in the right column. Scale bar=50 nm. The particles shown are representa-
tive of three independent puriﬁcations.−1.4 nm (n=36). The number of virus particles observed on the grids
was roughly equivalent between the viruses puriﬁed from 293TT and
Vero cells, indicating equivalent progeny production.
To examine the integrity of the NCCR of the puriﬁed virus, the
NCCR was PCR ampliﬁed and cloned, and ten clones were sequenced
from each virus. No rearrangements were identiﬁed in the archetype
virus NCCR, but one clone from the rearranged variant had a deletion
of the ﬁrst two P blocks of the Dunlop NCCR. Single nucleotide
changes were identiﬁed in each form, in 3 of 10 clones from the rear-
ranged variant and 1 of 10 clones from the archetype virus. The rear-
ranged variant base substitutions were T28C, A46G, and T322C,
where 1 is the ﬁrst nucleotide of the O block. The archetype virus sub-
stitution was C141T, which maps to the BKPyV TAg binding site III.
However, this substitution does not make the site more similar to
that of SV40 TAg binding site III, which may be expected if selection
for use of SV40 TAg were occurring.
Puriﬁed virus was treated with DNase to digest any unencapsi-
dated viral DNA and progeny virions were quantiﬁed by real-time
PCR. In a representative experiment, archetype virus puriﬁed from
293TT cells had 2.84×1011genomes/ml and rearranged virus had
1.65×1011genomes/ml. Infectivity of the puriﬁed virus was con-
ﬁrmed by infecting 293TT cells with 500 genomes/cell and measuring
VP1 expression at 1, 3, and 5 dpi (Fig. 5). Both puriﬁed archetype and
rearranged viruses were able to infect 293TT cells and showed an in-
crease in capsid protein over the ﬁve day time course. We noted no
difference in viral kinetics when cells were infected with equal ge-
nome numbers. Next we estimated the amount of infectious virus
present by infecting 293TT cells and immunostaining for VP1. As a
control to validate the assay, rearranged virus puriﬁed from Vero
cells was quantiﬁed by both VP1 immunostaining in 293TT cells and
TAg immunostaining in RPTE cells, a standard infectious unit (IU)
assay; it was calculated to have an equal titer in both assays. In the
representative experiment of virus whose genomes were quantiﬁed
above, the viral titers for archetype and rearranged virus were mea-
sured to be 2.14×108 and 2.40×107 IU/ml, respectively. In compari-
son, the yield from rearranged virus grown in Vero cells in three
fold more cells is, on average, 108 IU/ml. Archetype and rearranged
virus puriﬁed from 293TT cells therefore have a ratio of 1352 and
6875 genomes/IU, respectively. This result was reproducible. Taken
together, these results show that archetype BKPyV puriﬁed from
293TT cells is infectious and that the yields of infectious virus are similar
to those obtained with rearranged variants in Vero cells.
Discussion
BKPyV and JCPyV cause severe clinical disease in immunosup-
pressed and immunocompromised patients, respectively. It is thought
that the archetype form of these viruses is acquired in childhood or
early adulthood and establishes a persistent infection in the host. Thus
far, cell culture systems to propagate archetype polyomaviruses haveFig. 5. Puriﬁed archetype BKPyV is infectious in 293TT cells. 293TT cells were infected
with 500 genomes/cell of puriﬁed BKPyV and total cell protein was harvested 1, 3, and
5 dpi. 50 μg of protein was analyzed byWestern blotting for BKPyV TAg and GAPDH ex-
pression. A, archetype. R, rearranged. The blots shown are representative of three inde-
pendent experiments.
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we noted that archetype BKPyV replicated very poorly in RPTE cells, and
we showed here that when RPTE cells were transfected, the archetype
virus genome produced undetectable levels of TAg protein. Since TAg
is required to initiate viral DNA synthesis, we hypothesized that overex-
pression of TAg would stimulate archetype virus replication. We show
here that transient BKPyV TAg overexpression with archetype BKPyV
transfection is able to rescue DNA replication and capsid protein pro-
duction. Additionally we show that 293TT cells, which greatly overex-
press SV40 TAg, are capable of propagating both archetype BKPyV and
JCPyV. These viruses were able to replicate their DNA, express VP1,
and produce infectious progeny that were capable of reinfecting
293TT cells. This represents an improved culture model system for ar-
chetype BKPyV and JCPyV.
In addition to testing replication of archetype BKPyV and JCPyV,
we assessed three other unculturable polyomaviruses: MCPyV,
KIPyV, and WUPyV. Each of these viruses showed only minimal repli-
cation in 293TT cells as assessed by the DpnI resistance assay, akin to
what is seen for archetype BKPyV in RPTE cells (Broekema et al.,
2010). Additionally, KIPyV and WUPyV were unable to express de-
tectable levels of capsid protein. The TAg coding sequences of
MCPyV, KIPyV, andWUPyVhave only a 47.6%, 64.4%, and 62.8% similarity
to SV40 TAg, respectively, whereas BKPyV has 85.9% and JCPyV has
84.1% similarity. Our results suggest that SV40 TAg is likely not similar
enough to bind to and initiate replication from the MCPyV, KIPyV, and
WUPyV origins of replication.
It has been shown previously that SV40 TAg is capable of initiat-
ing replication from both the archetype and rearranged JCPyV and
BKPyV origins (Daniel et al., 1996; Mahon et al., 2009; Sock et al.,
1993). BKPyV TAg and JCPyV TAg also have the capacity to initiate
replication of BKPyV, JCPyV, and SV40 DNA, although replication of
SV40 DNA initiated by JCPyV TAg is limited. Our results show robust
replication of JCPyV at early timepoints post transfection of 293TT.
This is consistent with previous results showing replication of
JCPyV DNA initiated by SV40 TAg is better than that of BKPyV DNA
(Mahon et al., 2009). Archetype JCPyV DNA can replicate but not ef-
ﬁciently produce virus in POJ cells and COS-7 cells overexpressing
JCPyV and SV40 TAg, respectively (Daniel et al., 1996; Hara et al.,
1998; Nukuzuma et al., 2009). The difference in progeny production
of archetype JCPyV from COS-7 cells compared to 293TT cells likely
has to do with the very high levels of SV40 TAg produced in 293TT
cells. Furthermore, archetype BKPyV grown in 293TT cells is able to
produce as many IU/ml as rearranged virus grown in Vero cells, indi-
cating efﬁcient propagation. In contrast, previous research in a
human endothelial cell line, archetype BKPyV infectious progeny
production was poor and not detected until 35 dpt (Hanssen
Rinaldo et al., 2005).
Previous attempts to propagate archetype BKPyV in human em-
bryonic kidney cells resulted in selection for rearrangements
(Rubinstein et al., 1991). It also appears that signiﬁcant rearrange-
ment of the NCCR was selected for upon propagation in endothelial
cells (Hanssen Rinaldo et al., 2005). Therefore, we conﬁrmed the in-
tegrity of the regulatory regions of the viruses produced in 293TT
cells. Single nucleotide changes were observed in a minority of the
clones sequenced. These may be bona ﬁde mutations or possibly
PCR errors, although we did use high ﬁdelity Taq polymerase. Howev-
er, single base changes have been shown to be common in archetype
BKPyV and are not likely to affect replication (Yogo et al., 2008).
There was only one major rearrangement identiﬁed in one clone
from the BKPyV rearranged NCCR, which was a deletion of two of
three P blocks. However, no rearrangements were observed in the ar-
chetype virus regulatory region of BKPyV and JCPyV. These results
suggest that there is no selective pressure in 293TT cells to induce
rearrangements which might facilitate replication. The TEM images
of the puriﬁed BKPyV conﬁrm the identity of the puriﬁed virus as au-
thentic polyomavirus.Archetype JCPyV DNA replicates in COS-7, simian kidney cells
expressing SV40 TAg, and COS-7 cells expressing HIV-1 Tat (Hara et
al., 1998; Nukuzuma et al., 2009). However, these systems show
weak progeny production, taking up to 32 days to produce JCPyV as
detected by hemagglutination assay. Our system has the advantage
of faster progeny production, since we detect signiﬁcant titers, mea-
sured by infecting fresh 293TT cells with lysate harvested 7 dpt.
293TT cells are a human cell line and thus can be more effectively
used to study unique host-virus interactions that may be present,
such as interactions between cellular transcription factors and arche-
type virus promoters. However, since archetype virus replication in
293TT cells is driven by SV40 TAg, these cells cannot be used as a natural
host cell to study the life cycle of polyomaviruses. Regardless, these cells
will allow for further detailed comparative study of archetype polyoma-
viruses by providing a means for their propagation in the laboratory.
In conclusion, 293TT cells are able to support growth of the closely
related archetype BKPyV and JCPyV. Together, these ﬁndings strongly
suggest that TAg production is a limiting factor for archetype poly-
omavirus propagation in currently-available cell culture models.
Based on the results of this study, we speculate that cell culture sys-
tems overexpressing TAg from other unculturable polyomaviruses
may be able to support propagation of those viruses. The ﬁndings in
this paper expand our understanding of archetype virus and are an
early step toward characterizing the differences between archetype
and rearranged polyomaviruses. This study and knowledge gained
from future studies may lead to new approaches to prevent transmis-




Primary human RPTE cells were maintained for up to six passages
in renal epithelial growth medium as previously described (Abend et
al., 2007). 293TT cells were obtained from Chris Buck at the National
Cancer Institute (Buck et al., 2004) and were maintained under
400 μg/ml hygromycin selection in DMEM with 10% fetal bovine
serum and 100 U/ml penicillin, 100 μg/ml streptomycin.
Plasmids
The pBR322-Dunlop plasmid (ATCC #45025, pBKV) contains a full
length Dunlop (rearranged NCCR) genome (Seif et al., 1979) and the
pBR322-Dik plasmid contains a full length Dik (archetype NCCR) ge-
nome (Nishimoto et al., 2006). The Dik and Dunlop genomes each
were subcloned from these plasmids into pGEM7 at the BamHI site
to facilitate plasmid growth. The pJC-CY plasmid containing arche-
type JCPyV genome cloned into pUC19 at the BamHI site (Yogo et
al., 1990) was received from Richard Frisque at Pennsylvania State
University. The pBlu-WU and pBlu-KI plasmids were received from
David Wang at Washington University. We obtained pMCV-R17a
(Schowalter et al., 2010) from Addgene (plasmid 24729), where it
had been deposited by Chris Buck. The BKPyV TAg cDNA plasmid
was engineered for other purposes with a silent mutation at nucleo-
tide 4406 (Harris et al., 1998). For the present study, the cDNA was
subcloned into pcDNA3.1(+)-hygro (Invitrogen) using the BamHI
and EcoRI sites.
Transfection
The viral genome was excised from the vector backbone by BamHI
or EcoRI digestion (New England Biolabs, Ipswich, MA) and then
recircularized at a concentration of 10 ng/μL using T4 DNA ligase
(New England Biolabs). RPTE or 293TT cells were seeded into 12-
well plates and transfected with 0.5 μg DNA at 70–80% conﬂuency
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according to the manufacturer's instructions, with a DNA to transfec-
tion reagent ratio of 1:6. For the TAg cotransfection experiments,
0.5 μg of total DNA was transfected at a ratio of 1:9 of TAg to viral ge-
nome. Transfection complexes were removed 18 h post-transfection
by washing once with PBS and adding fresh media. DNA was
extracted from cell lysates by phenol-chloroform extraction, and the
integrity of the regulatory regions of BKPyV and JCPyV was conﬁrmed
in transfection lysates 7 dpt by cloning PCR products of the BKPyV
NCCR and JCPyV regulatory region (RR) into pGEM using primers
BKPyV NCCR Forward (5′ TTTGTCAGGGTGAAATTCCTT 3′) and
BKPyVV NCCR Reverse (5′ TCACCTCTACAAAATTCCAGCA 3′) and
JCPyV RR Forward (5′ GAATGTTTCCCCATGCAGAT 3′) and JCPyV RR
Reverse (5′ CTGTGCAAAAGTCCAGCAAA 3′). The PCR reaction con-
sisted of 0.5 μM each primer, 1 mM dNTPs, 2 mMMgSO4, and 1 U Pla-
timun Tag High Fidelity polymerase (Invitrogen) in 1× buffer
provided by the manufacturer. The PCR program consisted of an ini-
tial 5 min denaturation at 95 °C followed by 30 cycles each of dena-
turation at 95 °C for 45 s, annealing at 55 °C for 1 min, and
elongation at 68 °C for 1 min. The PCR product was puriﬁed using
the QIAquick PCR Puriﬁcation Kit (Qiagen), ligated into pGEM-T
Easy vector (Promega), transformed into E. coli ElectroTen Blue, and
clones were sequenced.
Southern blotting
DpnI resistance assays were performed as previously described
(Broekema et al., 2010) using low molecular weight DNA harvested
at the times stated in the text. For BKPyV, the probe was a 3239 bp
PvuII fragment excised from pGEM7-TU (Abend et al., 2007) which
spans the early region and the NCCR. The size marker was pGEM7-
TU digested with HindIII. For JCPyV, the probe was the whole
5120 bp JCPyV-CY genome excised from pJC-CY by BamHI digestion.
Western blotting
E1A lysis buffer was used to harvest total cell proteins, which were
analyzed as previously described (Jiang et al., 2009) with the following
modiﬁcations. The membrane was blocked for 30 min at room temper-
ature (RT) in 2% nonfat dried milk in PBS with 0.1% Tween 20 (PBS-T),
then incubated with primary antibody in 2% nonfat dried milk in PBS-
T for 2 h at RTor overnight at 4 °C. The following antibodies and concen-
trations were used: SV40 pAb416 (Harlow et al., 1981) for TAg at
1:3000; P5G6 (received from D. Galloway) for BKPyV VP1 at 1:10,000;
pAb597 (Atwood et al., 1995) (received from R. Frisque) for JCPyV
VP1 at 1:5000; WUPyV VP1 and KIPyV VP1 antibodies at 1:1000
(Nguyen et al., 2009) (received from D. Wang); and Ab9484 (Abcam)
for GAPDH at 1:10,000. The membrane was then washed 3×10 min
with PBS-T and incubated with horseradish peroxidase-conjugated
sheep anti-mouse antibody (Amersham) at 1:5000 in 2% nonfat dried
milk in PBS-T at RT for 2 h. The membrane was washed 3×10 min
and developed using HyGLO (Denville Scientiﬁc Inc.) or Luminol
(Millipore).
Virus puriﬁcation
Virus puriﬁcation was performed by density centrifugation on
CsCl gradients as previously described (Jiang et al., 2009). The mature
virus bands were collected by gravity ﬂow from the side of the centri-
fuge tube using an 18-gauge needle. The collected virus was dialyzed
against buffer A (10 mM HEPES [pH7.9], 1 mM CaCl2, 1 mM MgCl2,
5 mM KCl) overnight at 4 °C. The density of each band was deter-
mined by measuring the refractive index. The integrity of the NCCR
was conﬁrmed by cloning PCR products of the BKPyV NCCR using
primers BKPyV NCCR Forward and BKPyVV NCCR Reverse as de-
scribed above and sequencing 10 clones for each. Puriﬁed virus wasDNase-treated to digest unencapsidated viral DNA and progeny ge-
nomes were quantiﬁed by real-time PCR as previously described
(Jiang et al., 2011) using primers TAg-Forward (5′ TGTGATTGGGATT-
CAGTGCT 3′) and TAg-Reverse (5′ AAGGAAAGGCTGGATTCTGA 3′).
Infection
293TT cells were infected at 70–80% conﬂuency with 500 genomes/
cell of puriﬁed archetype or rearranged virus, or crude viral lysate, in
low serum media at 4 °C. After 1 h the infection media was replaced
with fresh warmed maintenance media. Viral titer was determined by
an infectious unit assay. Fifty percent conﬂuent 293TT cells were
infected at 4 °C with 10 fold dilutions of puriﬁed virus. Infection was
allowed to proceed for 3 dpi at 37 °C. The cells were then ﬁxed for
5 min in 95% ethanol/5% acetic acid and stained with the monoclonal
anti-VP1 antibody P5G6 (received from D. Galloway) at 1:500 followed
by a ﬂuorescein-conjugated anti-mouse antibody at 1:100. Viral titer
was determined by averaging ﬁve ﬁelds of view in triplicate infections.
Transmission electron microscopy
Dialyzed virus was diluted 1:10 in buffer A and applied to glow-
discharged 300-mesh copper grids (Electron Microscopy Sciences)
for 5 min at RT. Gridswere thenwashed in buffer A, ﬁxedwith glutaral-
dehyde, and stained with uranyl acetate as previously described
(Christensen et al., 2008).
Sequence alignment
TAg coding sequences were aligned by pairwise sequence align-
ment (http://www.ebi.ac.uk/Tools/psa/).
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